| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $352.7M | +6.5% |
| Cost of Revenue | $58.0M | +8.7% |
| Gross Profit | $294.7M | +6.1% |
| R&D Expense | $7.7M | +7.1% |
| SG&A Expense | $58.2M | +116.8% |
| Operating Income | $175.1M | -11.0% |
| Interest Expense | $14.3M | -81.2% |
| Pre-tax Income | $161.1M | +5.7% |
| Income Tax | $39.9M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.8M | -47.9% |
| Accounts Receivable | $24.8M | -41.2% |
| Current Assets | $96.3M | -51.5% |
| Total Assets | $562.8M | -62.3% |
| Current Liabilities | $78.0M | -61.9% |
| Long-term Debt | $792.0M | — |
| Total Liabilities | $895.5M | +142.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $233.7M | -2.1% |
| Capital Expenditures | $33.0M | +1.6% |
| Investing Cash Flow | -$42.5M | +30.3% |
| Financing Cash Flow | -$247.8M | -38.4% |
| Free Cash Flow | $200.7M | -2.7% |
| +32.8% |
| Net Income | $109.0M | -28.7% |
| EPS (Basic) | $5.46 | -28.9% |
| EPS (Diluted) | $5.44 | -29.2% |
| Stockholders' Equity |
| -$332.7M |
| -129.6% |